Clinical Trials in Tennessee

Showing 4041-4060 of 13,778 trials

A Trial of a Novel XPO1 Inhibitor in Participants With Advanced Solid Tumors

NCT02667873

Study SL-801-0115 is a dose-escalation study evaluating multiple doses and schedules of orally administered SL-801 in participants with advanced solid tumors.

Solid Tumors

Stemline Therapeutics, Inc.72 participantsStarted Feb 2016

New Haven, Connecticut, United States • Sarasota, Florida, United States • Nashville, Tennessee, United States +3 more locations

COMPLETEDPhase 229 miles

Open-Label Study of Setmelanotide in Hypothalamic Obesity

NCT04725240

Open-label, single-arm study designed to evaluate the body weight response to setmelanotide administered subcutaneously (SC) daily in participants with hypothalamic obesity (HO).

Hypothalamic Obesity

Rhythm Pharmaceuticals, Inc.18 participantsStarted Jun 2021

San Diego, California, United States • Gainesville, Florida, United States • Saint Paul, Minnesota, United States +2 more locations

Enrolling By Invitation29 miles

Brain Tissue Specimen Collection

NCT00593203

The Molecular Neurosurgical Tissue Bank will function as a tissue or specimen repository for biopsy specimens from patients (both adult and pediatric) undergoing brain surgery and brain procedures.

Brain Diseases

Vanderbilt University Medical Center2,500 participantsStarted May 2003

Nashville, Tennessee, United States

A Trial of a Novel XPO1 Inhibitor in Participants With Advanced Solid Tumors

Open-Label Study of Setmelanotide in Hypothalamic Obesity

Brain Tissue Specimen Collection

Find Trials by Condition in Tennessee

Effects of a Virtual Reality Intervention on Mental Health Outcomes and Academic Success in Physical Therapy Students

Different Doses of Naronapride Vs. Placebo in Gastroparesis

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements

DS-3201b in Participants With Lymphomas

Surveillance and Alert-based Multiparameter Monitoring to Reduce Worsening Heart Failure Events

A Phase 2b Study of BNC210 Tablet Formulation in Adults With Post-Traumatic Stress Disorder (PTSD)

A Multi-Center, Randomized, Double Masked, Parallel-Group, Vehicle-Controlled, Clinical Study to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease

Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Medium Dose Inhaled Corticosteroid (ICS).

Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration

(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations

A Study of SGN-ALPV in Advanced Solid Tumors

Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer

A Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation

Safety and Immunogenicity of CodaVax-RSV in Seropositive and Seronegative Children

Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy

Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors